Machine learning-based nomogram for mortality risk stratification in cirrhotic patients with sepsis: a single-center
Xing-Cheng Zhang1,2, Bo-Wen Li3, Xi-Qun Lei2
1The First Department of Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Frontiers in Medicine
|November 6, 2025
Summary
A new nomogram model effectively predicts in-hospital mortality for liver cirrhosis patients with sepsis. This tool aids clinical decisions and early interventions for high-risk individuals.
Area of Science:
- Hepatology
- Critical Care Medicine
- Medical Informatics
Background:
- Sepsis is a life-threatening complication in liver cirrhosis patients.
- Predicting in-hospital mortality in this population is crucial for timely intervention.
- Existing predictive models may lack accuracy or clinical utility.
Purpose of the Study:
- To develop and validate a nomogram-based predictive model for in-hospital mortality in liver cirrhosis patients with sepsis.
- To evaluate the model's predictive accuracy and clinical usefulness.
Main Methods:
- Retrospective collection of clinical data from 264 liver cirrhosis patients with sepsis.
- Development of a predictive model using Lasso regression on a training set (70%) and validation on a separate set (30%).
- Evaluation of the nomogram's performance using ROC curves, calibration plots, and decision curve analysis (DCA).
Main Results:
- The nomogram identified alcoholic cirrhosis, Child-Pugh score, mechanical ventilation, TBiL, and HR as independent predictors of mortality.
- The model demonstrated strong predictive performance with AUCs of 0.81 (training) and 0.83 (validation).
- Calibration plots showed good agreement between predicted and observed mortality, and DCA indicated significant clinical net benefit.
Conclusions:
- The developed nomogram model shows promising predictive potential for in-hospital mortality in this patient cohort.
- This tool can support clinical decision-making and guide early interventions for high-risk patients.
- Further validation in diverse clinical settings is warranted to confirm its broad applicability.


